Correction to: The effective threshold dose of etanercept in patients with methotrexate-resistant rheumatoid arthritis

被引：0
|
作者：
Fangfang Chen
Yitian Lang
Shikai Geng
Xiaodong Wang
Liangjing Lu
Shuang Ye
Le Zhang
Ting Li
机构：
[1] Ren Ji Hospital,Department of Rheumatology
[2] Shanghai Jiaotong University School of Medicine,Department of Pharmacy
[3] Ren Ji Hospital,Department of Pharmacy
[4] Shanghai Jiaotong University School of Medicine,undefined
[5] Huangpu Branch,undefined
[6] Shanghai Ninth People’s Hospital,undefined
[7] Shanghai Jiaotong University School of Medicine,undefined
来源：
Clinical Rheumatology | 2023年 / 42卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2923 / 2923
相关论文
共 50 条
  • [31] Pharmacokinetics of etanercept are unaltered by concurrent administration of methotrexate in rheumatoid arthritis patients
    Zhou, H
    Zitnik, R
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (03) : A53 - A53
  • [32] TOFACITINIB IMPROVES ARTERIAL STIFFNESS WITH METHOTREXATE-RESISTANT ACTIVE RHEUMATOID ARTHRITIS. A COHORT STUDY
    Kume, K.
    Amano, K.
    Yamada, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 961 - 961
  • [33] Remission of methotrexate-resistant rheumatoid arthritis after receiving 5-fluorouracil for colon cancer
    Jensen, AO
    Mejer, J
    JOURNAL OF INTERNAL MEDICINE, 2003, 254 (04) : 395 - 396
  • [34] Leflunomid versus cyclosporin in methotrexate-resistant rheumatoid arthritis in Poland: A cost-effectiveness analysis
    Golicki, D.
    Niewada, M.
    Lis, J.
    Kaminski, B.
    Jakubczyk, M.
    Macioch, T.
    VALUE IN HEALTH, 2007, 10 (06) : A245 - A245
  • [35] The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy
    van der Heijde, D.
    Burmester, G.
    Melo-Gomes, J.
    Codreanu, C.
    Mola, E. Martin
    Pedersen, R.
    Freundlich, B.
    Chang, D. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (02) : 182 - 188
  • [36] The secondary addition of methotrexate partial responders to etanercept alone is effective in severe rheumatoid arthritis
    Cohen, J
    Zaltni, S
    Kaiser, MJ
    Jorgensen, C
    Bozonnat, MC
    Daurès, JP
    Sany, J
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 167 - 168
  • [37] Secondary addition of methotrexate to partial responders to etanercept alone is effective in severe rheumatoid arthritis
    Cohen, JD
    Zaltni, S
    Kaiser, MJ
    Bozonnat, MC
    Jorgensen, C
    Daurès, JP
    Sany, J
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (02) : 209 - 210
  • [38] Effectiveness of dose reduction of etanercept and adalimumab in patients with rheumatoid arthritis
    Rosalía Martínez-Pérez
    Sergio Rodríguez-Montero
    Alejandro Muñoz
    Julia Uceda
    Mario León
    Francisco Gallo
    Maria Luisa Velloso
    José Luis Marenco
    Journal of Translational Medicine, 9 (Suppl 2)
  • [39] Etanercept is effective in patients with rheumatoid arthritis with no response to infliximab therapy
    Gómez-Puerta, JA
    Sanmartí, R
    Rodríguez-Cros, JR
    Cañete, JD
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (07) : 896 - 896
  • [40] Etanercept improves rheumatoid arthritis partially responsive to methotrexate
    Cutolo, M
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2001, 19 (06) : 626 - 627
12345